Kistler-Tiffany Companies’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $33 | Hold |
100
| – | – | ﹤0.01% | 894 |
|
|
2023
Q1 | $43 | Hold |
100
| – | – | ﹤0.01% | 789 |
|
|
2022
Q4 | $53 | Hold |
100
| – | – | ﹤0.01% | 802 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 833 |
|
|
2022
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 805 |
|
|
2022
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 783 |
|
|
2021
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 769 |
|
|
2021
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 761 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 722 |
|
|
2021
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 699 |
|
|
2020
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 691 |
|
|
2020
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 655 |
|
|
2020
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2020
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 559 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 565 |
|
|
2019
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 580 |
|
|
2019
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 569 |
|
|
2019
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 562 |
|
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 578 |
|
|
2018
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 550 |
|
|
2018
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 558 |
|
|
2018
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 548 |
|
|
2017
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 545 |
|
|
2017
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 537 |
|
|
2017
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 474 |
|
|
2017
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 482 |
|